已收盤 11-01 16:00:00 美东时间
0.000
0.00%
Replimune stock falls as FDA denies skin cancer drug approval and investors sue over alleged misstatements tied to the IGNYTE trial.
2025-08-05 00:43
An update from Replimune Group (REPL) is now available. Replimune Group, Inc. h...
2024-06-06 22:03
Ignyte Acquisition (NASDAQ:IGNY – Get Rating) and Icosavax (NASDAQ:ICVX – Get R...
2023-04-24 14:33
VectivBio (NASDAQ:VECT – Get Rating) and Ignyte Acquisition (NASDAQ:IGNY – Get ...
2023-03-11 14:04
argenx (NASDAQ:ARGX – Get Rating) and Ignyte Acquisition (NASDAQ:IGNY – Get Rat...
2022-12-25 14:11
北京时间2022年10月26日21时57分,Ignyte Acquisition Corp(IGNY.us)股票出现异动,股价急速上涨6.50%。截至发稿,该股...
2022-10-26 22:32
Ignyte Acquisition (NASDAQ:IGNY – Get Rating) and Inhibikase Therapeutics (NYSE...
2022-09-07 14:02
Context Capital Management LLC bought a new position in shares of Ignyte Acquis...
2022-08-12 20:21
生物制药公司Peak Bio、医疗技术公司SeaStar Medical拟在纳斯达克上市;据报道,陈德霖、曾璟璇发起的SPAC公司通过上市聆讯 >>
2022-04-29 21:00
北京时间2022年04月29日02时43分,Ignyte Acquisition Corp Unit 1 Com & 1/2 Wt Exp(05/01...
2022-04-29 03:19